![]() |
市場調查報告書
商品編碼
1404769
乳房重建市場規模、佔有率、趨勢分析報告:按產品、按形狀、按最終用途、按地區、細分市場預測,2024-2030 年Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander), By Shape (Round, Anatomical), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030 |
根據Grand View Research, Inc.最新報告,預計到2030年,全球乳房重建市場規模將達到31.5億美元,2024年至2030年複合年成長率為6.54%。
由於乳癌的高發病率、重組手術數量的增加以及人們對乳房重建技術可用性的認知不斷增強,預計該市場將顯著成長。乳癌是世界上最常見的癌症。根據國際癌症研究機構的數據,2022年,全球新增乳癌病例約2,261,419例,同年死亡人數為9,958,133人;同一來源估計,到2025年這一數字將增加。預計這一數字將增加至7,790,717人人們。因此,由於乳癌患者數量的增加,預計該行業在未來幾年將成長。
新產品的推出、地理擴張、合作夥伴關係以及領先企業的各種策略舉措也支持了該行業的成長。總部位於美國的主要企業包括 Allergan(現為 AbbVie 的一部分)、Mentor(Johnson & Johnson 的子公司)、Sientra、Establishment Labs SA 和 Ideal Implant Inc。這個國家有主要企業,市場競爭非常激烈。每家公司都在採取各種措施來擴大其在行業中的影響力。例如,2023 年 6 月,Sientra, Inc. 的 AlloX2 Pro 組織擴張器獲得 FDA核准。乳房重建手術的日益普及,加上女性對這些美容手術的認知不斷提高,是市場的關鍵驅動力。乳房重建手術是女性在乳房切除術後主要選擇的乳房增大或乳房重建手術,預計將在預測期內推動該行業的成長。
The global breast reconstruction market size is expected to reach USD 3.15 billion by 2030, registering a CAGR of 6.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth due to the high incidence of breast cancer, increasing volume of reconstructive surgeries, and rising awareness regarding the availability of breast reconstruction procedures. Breast cancer is the most prevalent cancer worldwide. As per the International Agency for Research on Cancer in 2022, about 2,261,419 new breast cancer cases were recorded globally with 9,958,133 deaths in the same year; the same source stated that the number is expected to increase to 7,790,717 by 2025. Thus, with a rise in the number of breast cancer patients, the industry is expected to grow over the coming years.
New product launches, geographic expansions, partnerships, and various strategic initiatives undertaken by major players also support industry growth. Some of the key players, headquartered in the U.S., include Allergan (now part of AbbVie); Mentor (a subsidiary of Johnson & Johnson); Sientra, Establishment Labs S.A.; and Ideal Implant Inc. Due to the presence of leading players in this country, the market is highly competitive. Companies are undertaking various initiatives to strengthen their industry presence. For instance, in June 2023, Sientra, Inc. received FDA approval for its AlloX2 Pro Tissue Expander. Increasing adoption of breast reconstruction surgeries, combined with a growing awareness among women regarding these procedures for aesthetic enhancement, represents a significant catalyst for the market. Women predominantly opt for this surgery to augment breast size and reconstruct breasts following mastectomy, which is expected to fuel industry growth over the forecast period.
List of Figurs
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Breast Reconstruction Market revenue, 2018 - 2030 (USD Million)
Fig. 10 Breast Reconstruction Market snapshot
Fig. 11 Breast Reconstruction Market driver impact
Fig. 12 Breast Reconstruction Market restraint impact
Fig. 13 Porter's 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 Breast reconstruction market: Product movement analysis
Fig. 16 Segment dashboard
Fig. 17 Breast reconstruction market product outlook: Key takeaways
Fig. 18 Implants market, 2018 - 2030 (USD Million)
Fig. 19 Silicone breast implants market, 2018 - 2030 (USD Million)
Fig. 20 Saline breast implants market, 2018 - 2030 (USD Million)
Fig. 21 Tissue expander market, 2018 - 2030 (USD Million)
Fig. 22 Saline expander market, 2018 - 2030 (USD Million)
Fig. 23 Air tissue expander market, 2018 - 2030 (USD Million)
Fig. 24 Acellular dermal matrix market, 2018 - 2030 (USD Million)
Fig. 25 Breast reconstruction market shape outlook: Key takeaways
Fig. 26 Round shape market, 2018 - 2030 (USD Million)
Fig. 27 Anatomical shape market, 2018 - 2030 (USD Million)
Fig. 28 Breast reconstruction market end-use outlook: Key takeaways
Fig. 29 Hospitals market, 2018 - 2030 (USD Million)
Fig. 30 Cosmetology clinics market, 2018 - 2030 (USD Million)
Fig. 31 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 32 Regional outlook, 2023 & 2030
Fig. 33 Regional market dashboard
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 Breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 36 North America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 37 US breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 38 Canada breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 39 Europe breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 40 UK breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 41 Germany breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 42 France breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 43 Italy breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 44 Spain breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 45 Denmark breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 46 Sweden breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 47 Norway breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 49 Japan breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 50 China breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 51 India breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 52 Australia breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 53 South Korea breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 54 Thailand breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 55 Latin America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 56 Brazil breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 57 Mexico breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 58 Argentina breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 59 Middle East & Africa breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 60 South Africa breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 62 UAE breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 63 Kuwait breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 64 Company market share analysis, 2023
Fig. 65 Market differentiators
Fig. 66 Regional network map